Lisbon, Portugal, September 2025 – Microinnova Engineering has entered into a strategic partnership with Hovione, a global leader in pharmaceutical development and manufacturing, to accelerate the adoption of modular flow chemistry technologies in multi-purpose manufacturing.
As part of this collaboration, Microinnova’s next-generation modular equipment will be deployed to an industrial setting at Hovione. The equipment is designed to provide flexibility, scalability, and efficiency in active ingredient production while supporting more sustainable operations. By combining forces, the two companies aim to shorten process development timelines, simplify scale-up from lab to commercial production, and reduce time-to-market for pharmaceutical customers. Dr. Dirk Kirschneck, Founder and Strategic Director at Microinnova, said:
“This partnership reflects our shared vision to deliver modular manufacturing technologies that support pharmaceutical innovation and manufacturing excellence. We are proud to join forces with Hovione to showcase the capabilities of our next-generation modular equipment in a dynamic CDMO environment, demonstrating its versatility for multi-purpose manufacturing.”
Hovione’s CEO, Dr. Jean-Luc Herbeaux, emphasized the importance of our partnership for the future of drug development:
“This collaboration with Microinnova underscores Hovione’s commitment to innovation in pharmaceutical manufacturing, with flow chemistry playing an important role in our long-term drug substance strategy. This partnership will allow us to shape and validate emerging continuous manufacturing technologies, which can potentially accelerate drug development and production.”
With over 20 years of experience and more than 250 successful projects, Microinnova is recognized as a trusted partner for continuous manufacturing and process intensification. This collaboration highlights our commitment to bringing modular, flexible, and future-proof solutions to the pharmaceutical industry.